CytoDyn Inc.
CYDY
$0.2926
-$0.0034-1.15%
OTC PK
Corporate Info
Website
Phone Number
360 980 8524
Address
1111 Main Street
Suite 660
Vancouver, WA 98660
Suite 660
Vancouver, WA 98660
Country
United States
Year Founded
2002
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
Business Decription
CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company’s leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.